Purespring Therapeutics Revenue

Biotechnology Research • London, England, United Kingdom • 51-100 Employees

Purespring Therapeutics revenue & valuation

Annual revenue	$5,047,745
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$16,200,000
Total funding	$164,100,000

Key Contacts at Purespring Therapeutics

Haseeb Ahmad

Chief Executive Officer

Moin Saleem

Founder And Chief Scientific Advisor

Julian Hanak

Chief Executive Officer

Company overview

Headquarters	2 Royal College Street, The London Bioscience Innovation Centre, London, NW1 0NH, GB
Phone number	+442038556324
Website	purespringtx.com
NAICS	541714
Keywords	Biotechnology, Gene Therapy, Kidney Diseases
Founded	2020
Employees	51-100
Socials

Purespring Therapeutics Email Formats

Purespring Therapeutics uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@purespringtx.com), used 63.3% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@purespringtx.com	63.3%
{first name}.{last name}	john.doe@purespringtx.com	30.6%
{last name}.{last name}	doe.doe@purespringtx.com	6.1%

About Purespring Therapeutics

Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Senior

Employees by Department

Purespring Therapeutics has 19 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore Purespring Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-12-19	4	$59,600,000
2024-11-09	5	$104,500,000

Funding Insights

$164,100,000

Total funding amount

$104,500,000

Most recent funding amount

Number of funding rounds

Purespring Therapeutics Tech Stack

Discover the technologies and tools that power Purespring Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Howler.js

JavaScript libraries

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

Flickity

JavaScript libraries

WordPress

Blogs

Frequently asked questions

Purespring Therapeutics is located in London, England, GB.

You can reach Purespring Therapeutics at +442038556324.

Purespring Therapeutics generates an estimated annual revenue of $5,047,745. This revenue figure reflects the company's market position and business performance in its industry.

Purespring Therapeutics has an estimated valuation of $16,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Purespring Therapeutics was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Purespring Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Purespring Therapeutics has raised a total of $164,100,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Purespring Therapeutics

Haseeb Ahmad

Chief Executive Officer

Moin Saleem

Founder And Chief Scientific Advisor

Julian Hanak

Chief Executive Officer

4.8

40,000 users